Latest Financials News

ImpediMed has secured A$15.2 million through a two-tranche placement and share purchase plan, alongside A$5 million in cost reductions, aiming for operating cashflow breakeven by H2 FY28.

Celsius Resources is probing an unauthorized directive by an executive to transfer shares in Makilala Mining, leading to the termination of the executive's consulting role amid ongoing ownership conflicts.

Following the granting of a 25-year mining permit, AKORA Resources has launched a $3.3 million capital raising to fund development and financing activities at its high-grade Bekisopa iron ore project in Madagascar.

NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.

Arovella Therapeutics undergoes a major board overhaul and CEO resignation following a shareholder push, as the company embarks on a strategic review of its cell therapy platform.

Beetaloo Energy has secured full underwriting for its $5 million Share Purchase Plan, with shareholder approval for the share issuance and any shortfall shares to be sought at the upcoming AGM on 29 May 2026.

Stellar Resources has raised $22.1 million through a placement led by Metals X, boosting its cash reserves to $33 million and setting the stage for key feasibility studies at Heemskirk.

Legacy Minerals reveals a robust 19-year Mt Carrington gold-silver project with a pre-tax NPV of A$716 million and low operating costs, advancing towards pre-feasibility studies amid resource conversion plans.

Navigator Global Investments (ASX: NGI) is acquiring a US$195 million portfolio of Net Revenue Share interests from Stable Asset Management, broadening its alternative asset manager ecosystem and raising A$145 million via a fully underwritten entitlement offer.

Australian Mines Limited has raised $3 million through a strategic placement led by Tribeca Investment Partners to fast-track its Flemington Scandium Project from scoping to pre-feasibility study, aiming to de-risk and advance permitting.

Botala Energy Ltd has denied holding undisclosed information following a sharp share price rise, linking the spike to a recent Serowe CBM Project announcement and confirming compliance with ASX disclosure rules.

The Hydration Pharmaceuticals Company Limited (ASX: HPC) has had its trading suspension lifted as of 4 May 2026, following the lodgement of its delayed Annual Report revealing a $2.86 million net loss.